| Year |
Citation |
Score |
| 2014 |
Irshad S, Lawler K, Flores-Borja F, Monypenny J, Evans R, Grigoriadis A, Fruhwirth G, Cheung A, Barber P, Ellis PA, Tutt ANJ, Ng T. Effect of lymphoid tissue inducer cells on lymphatic tumor cell invasion via activation of the RANKL/RANK axis within triple-negative breast cancers. Journal of Clinical Oncology. 32: 11082-11082. DOI: 10.1200/Jco.2014.32.15_Suppl.11082 |
0.321 |
|
| 2013 |
Ramsay AG, Evans R, Kiaii S, Svensson L, Hogg N, Gribben JG. Chronic lymphocytic leukemia cells induce defective LFA-1-directed T-cell motility by altering Rho GTPase signaling that is reversible with lenalidomide. Blood. 121: 2704-14. PMID 23325833 DOI: 10.1182/Blood-2012-08-448332 |
0.328 |
|
| 2013 |
Irshad S, Lawler K, Evans R, Flores-Borja F, Monypenny J, Grigoriadis A, Fruhwith G, Poland S, Barber P, Vojnovic B, Ellis P, Tutt A, Ng T. Abstract P5-01-01: Lymphoid tissue inducer cells: Identification of a novel immune cell within the breast tumour microenvironment and its role in promoting tumour cell invasion Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P5-01-01 |
0.318 |
|
| 2012 |
Evans RW, Kong X, Hider RC. Iron mobilization from transferrin by therapeutic iron chelating agents. Biochimica Et Biophysica Acta. 1820: 282-90. PMID 22155077 DOI: 10.1016/J.Bbagen.2011.11.007 |
0.406 |
|
| 2011 |
Carlin LM, Evans R, Milewicz H, Fernandes L, Matthews DR, Perani M, Levitt J, Keppler MD, Monypenny J, Coolen T, Barber PR, Vojnovic B, Suhling K, Fraternali F, Ameer-Beg S, et al. A targeted siRNA screen identifies regulators of Cdc42 activity at the natural killer cell immunological synapse. Science Signaling. 4: ra81. PMID 22126964 DOI: 10.1126/Scisignal.2001729 |
0.302 |
|
| 2010 |
Ramsay AG, Evans R, Svensson L, Kiaii S, Hogg N, Gribben JG. Defective LFA-1 Mediated T Cell Motility In Chronic Lymphocytic Leukemia Is Mediated by Defects In the Rho GTPase Signaling Pathway Blood. 116: 914-914. DOI: 10.1182/Blood.V116.21.914.914 |
0.303 |
|
| 2008 |
Devanur LD, Evans RW, Evans PJ, Hider RC. Chelator-facilitated removal of iron from transferrin: relevance to combined chelation therapy. The Biochemical Journal. 409: 439-47. PMID 17919118 DOI: 10.1042/Bj20070823 |
0.403 |
|
| 2008 |
Evans RW, Rafique R, Zarea A, Rapisarda C, Cammack R, Evans PJ, Porter JB, Hider RC. Nature of non-transferrin-bound iron: studies on iron citrate complexes and thalassemic sera. Journal of Biological Inorganic Chemistry : Jbic : a Publication of the Society of Biological Inorganic Chemistry. 13: 57-74. PMID 17906879 DOI: 10.1007/S00775-007-0297-8 |
0.398 |
|
| 1998 |
Kremlev SG, Chapoval AI, Evans R. Cytokine release by macrophages after interacting with CSF-1 and extracellular matrix proteins: characteristics of a mouse model of inflammatory responses in vitro. Cellular Immunology. 185: 59-64. PMID 9636683 DOI: 10.1006/Cimm.1998.1276 |
0.316 |
|
| 1997 |
Kamdar SJ, Fuller JA, Evans R. CSF-1-induced and constitutive 116 gene expression in mouse macrophages: Evidence for PKC-dependent and -independent pathways Experimental Cell Research. 232: 439-442. PMID 9168824 DOI: 10.1006/Excr.1997.3551 |
0.308 |
|
| 1996 |
Kamdar SJ, Chapoval AI, Phelps J, Fuller JA, Evans R. Differential sensitivity of mouse mononuclear phagocytes to CSF-1 and LPS: The potential in vivo relevance of enhanced IL-6 gene expression Cellular Immunology. 174: 165-172. PMID 8954616 DOI: 10.1006/Cimm.1996.0306 |
0.313 |
|
| 1994 |
Evans R, Kamdar SJ, Duffy TM. Qualitative and quantitative intratumoral changes in gene expression following cyclophosphamide injection and the adoptive transfer of T cells: The potential contribution of tumor-associated macrophages International Journal of Cancer. 56: 568-573. PMID 8112893 DOI: 10.1002/Ijc.2910560417 |
0.337 |
|
| 1992 |
Evans R, Kamdar SJ, Duffy TM, Fuller J. Synergistic interaction of bacterial lipopolysaccharide and the monocyte-macrophage colony-stimulating factor: Potential quantitative and qualitative changes in macrophage-produced cytokine bioactivity Journal of Leukocyte Biology. 51: 93-96. PMID 1371299 DOI: 10.1002/Jlb.51.1.93 |
0.307 |
|
| 1989 |
Evans R, Duffy TM, Coleman DL, Tai HH. Partial characterization of a low-molecular-weight, macrophage-derived inhibitor of DNA synthesis: A possible immunoregulatory molecule Cellular Immunology. 119: 53-66. PMID 2920397 DOI: 10.1016/0008-8749(89)90223-2 |
0.327 |
|
| 1989 |
Evans R, Duffy TM, Blake SS, Lin HS. Regulation of systemic macrophage IL-1 gene transcription: the involvement of tumor-derived macrophage growth factor, CSF-1 Journal of Leukocyte Biology. 46: 428-433. PMID 2681489 DOI: 10.1002/Jlb.46.5.428 |
0.342 |
|
| 1989 |
Evans R, Duffy TM. Adoptive immunotherapy is suppressed in C57BL/6J and B6.C-H-2(bm12) mice following recognition of congenic class II MHC antigen determinants International Journal of Cancer. 44: 854-858. PMID 2479606 DOI: 10.1002/Ijc.2910440518 |
0.327 |
|
| 1986 |
Evans R, Blake SS, Saffer JD. Expression of class II-MHC antigens by tumor-associated and peritoneal macrophages: systemic induction during tumor growth and tumor rejection. Journal of Leukocyte Biology. 40: 499-509. PMID 3464672 DOI: 10.1002/Jlb.40.5.499 |
0.301 |
|
| 1983 |
Evans R, Eidlen DM. Predisposition of [125I]5-iodo-2'-deoxyuridine-labeled normal and neoplastic mouse fibroblasts to lysis by normal macrophages. Journal of the National Cancer Institute. 71: 983-989. DOI: 10.1093/Jnci/71.5.983 |
0.348 |
|
| Show low-probability matches. |